Baseline & Follow-up Information

As of July 2019, all of our study documentation for baselines and follow-ups will be accessible from the BADBIR database. This will mean you can log into the BADBIR database to download and print the documents.

Once you log in, click the Questionnaires link on the top menu, as shown below.

Questionnaires menu link

You will be able to download all of the documents as usual, and we will keep the page up-to-date with the latest BADBIR questionnaires.

This page now serves as a list of all documents and their version numbers, for reference.

All BADBIR Documents

Name Version Details
Patient Information Sheet 5.1 Must be printed on Trust-headed paper
Patient Consent Form 5.1 Must be printed on Trust-headed paper
Participant Information Sheet 2.1 For very young children, guide: under 6
Participant Information Sheet 2.1 For young children, guide: 6-10
Participant Information Sheet 2.1 For children, guide: 11-16
Patient Assent Form 5.1 For the participant to sign
Participant Consent Form for Parent/Guardian 5.1 For the parent or guardian to sign
Baseline Registration Checklist 9 This is a registration checklist, clinical questionnaire, patient questionnaire and QOLs in one document (now updated with the latest study drugs).
Clinical Baseline Questionnaire 9 Now updated with the latest study drugs.
Patient Baseline Questionnaire 5 Corresponds to the Lifestyle Factors page on the database.
Paediatric Patient Baseline Questionnaire 5 Please ask patient to complete all relevant questions
Patient QOL Questionnaires This contains the CAGE, DLQI, EQ-5D (EuroQOL), HAQ and HADS in one document.
CDLQI Children's Dermatology Life Quality Index
CDLQI cartoon version Children's Dermatology Life Quality Index for younger children
EQ-5D-Y Children's EQ-5D (EuroQol)
CHAQ Childhood Health Assessment Questionnaire (applicable if the patient has a diagnosis of Inflammatory Arthritis)
Follow-up Checklist 9 This is a follow-up checklist, clinical questionnaire and QOLs in one document. Now updated to version 9.
Clinical Follow-up Questionnaire 9 Updated to include Imraldi (Adalimumab biosimilar) and adverse event format changes.
Patient Follow-up Questionnaire 6 Medical Problems, DLQI, EQ-5D (EuroQol), CAGE